Licensing deals on generic versions of Roche flu drug aimed at preparing for pandemic Eleven companies will be permitted to develop, manufacture, and supply Xofluza in 129 countries

https://www.statnews.com/pharmalot/2026/09/25/roche-xofluza-influenza-treatment-agreements/ By Ed SilvermanSept. 25, 2026 Pharmalot Columnist, Senior Writer

Ohio governor’s race is a battle over Covid, health costs, and trust in science The tight contest between physician Amy Acton and biotech entrepreneur Vivek Ramaswamy is a proxy for tensions in the heartland

https://www.statnews.com/2026/09/22/ohio-governor-election-health-care-policy-acton-ramaswamy/ By Sarah ToddSept. 22, 2026 Reporter, Commercial Determinants of Health

Skeptical about modern medicine? I know the feeling — and want to listen As STAT’s trust-in-science reporter, my hope is to better understand how doubt takes hold

https://www.statnews.com/2026/09/21/trust-in-science-nick-florko-on-understanding-growing-scientific-mistrust/ By Nicholas FlorkoSept. 21, 2026 Trust-in-Science Reporter

Drugmakers, biotech VCs show ‘reinvigorated’ interest in osteoporosis treatments Shift by the FDA and frustration with existing therapies have created new opportunities

https://www.statnews.com/2026/09/23/biotech-vc-investors-new-opportunity-osteoporosis-treatments/ By Allison DeAngelisSept. 23, 2026 Biotech Startups and Venture Capital Reporter

Trump administration uses rare authority to claw back nearly $1B in spending approved by Congress Most of the cuts are focused on HHS programs that serve refugees, unaccompanied minors

https://www.statnews.com/2026/09/25/trump-administration-cancel-spending-hhs-programs/ By Associated PressSept. 25, 2026

I worked on the CDC investigation of the anthrax letters. 25 years later, are we ready for the next biothreat? The anthrax letters offer us three lessons for today

I worked on the CDC investigation of the anthrax letters. 25 years later, are we ready for the next biothreat? The anthrax letters offer us three lessons for today https://www.statnews.com/2026/09/26/anthrax-letters-25th-anniversary-cdc-investigation-new-biothreats-ai/ By Daniel JerniganSept. 26, 2026 Jernigan is a contributing scholar at Johns Hopkins Bloomberg School of Public Health and previously served 31 years at CDC.

The Health Risks of AI